Loading
Latest filing published 06 Mar 2023 for Concert Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter Barton Hutt appears in our data through filings on Concert Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 10 June 2021 and the latest from 6 March 2023.
Sales make up the whole of the open-market record (1 sale, €22k). Other entries cover 2 share grants and 1 option exercise.
The record was last updated on 6 March 2023 with a transaction in Concert Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations